What follow-up tests do I need after HER2-Positive Breast Cancer treatment ends

HER2-Positive Breast CancerMay 20, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Follow-Up Testing After HER2-Positive Breast Cancer Treatment

Great question—understanding your follow-up care plan is an important part of your survivorship. Let me walk you through what the standard recommendations are based on current guidelines.

Regular Medical Visits & Physical Exams

According to NCCN Guidelines for Invasive Breast Cancer, your follow-up care should include:

  • Medical history and physical exams: 1 to 4 times per year as needed for the first 5 years, then every year after that
  • Your care team will monitor you for any signs of recurrence (cancer returning) and side effects from treatment

Imaging Tests

Mammograms are a key part of follow-up:

  • Every 12 months (annually)
  • Can start as soon as 6 months after breast-conserving therapy (if you had that type of surgery)
  • Note: Mammograms are not needed on the side where you had a mastectomy or on a reconstructed breast

Heart tests may be needed because some HER2-targeted therapies (like trastuzumab) can affect heart function. Your doctor will determine if and when these are necessary based on your specific treatment.

Additional Monitoring

The NCCN Guidelines recommend:

  • Screening for emotional health: Your care team should check in about anxiety, depression, and distress
  • Genetic counseling referral: If not already done, discuss whether genetic testing is appropriate for your situation
  • Lymphedema monitoring: Watch for swelling in your arm or chest wall; ask for a referral to lymphedema management if needed
  • Blood and imaging tests: Only if you develop signs or symptoms that suggest possible metastases (cancer spread)

If You're on Ongoing Therapy

If your treatment plan includes extended HER2-targeted therapy (like trastuzumab) or endocrine therapy (hormone therapy):

  • Continue taking all medications exactly as prescribed
  • Don't miss or skip doses—consistency is important
  • Report any side effects to your care team

Important Symptoms to Report

Tell your care team immediately if you experience:

  • Headaches
  • Shortness of breath (especially with walking or activity)
  • Bone pain
  • Any new or unusual symptoms

Your Personalized Survivorship Plan

According to NCCN Guidelines, you should receive a personalized survivorship care plan that includes:

  • A summary of your cancer treatment
  • Possible long-term side effects to watch for
  • Clear follow-up recommendations
  • How your primary care doctor will coordinate with your cancer specialists

Lifestyle Recommendations

The guidelines also emphasize:

  • Maintain an ideal body weight (BMI of 20-25)
  • Be physically active
  • Eat a mostly plant-based diet
  • Limit alcohol use
  • Avoid smoking/vaping

Questions to Ask Your Oncology Team

Since your specific situation is unique, make sure to discuss:

  1. "What is MY specific follow-up schedule for the next 5 years?" (Frequency may vary based on your stage and risk factors)

  2. "Do I need heart function tests, and if so, how often?" (This is especially important with HER2-targeted therapies)

  3. "Will I continue any medications after my active treatment ends, and for how long?"

  4. "What symptoms should prompt me to call you immediately versus waiting for my next appointment?"

  5. "Can you provide me with a written survivorship care plan that I can share with my primary care doctor?"


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: